| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 03/16/2011 | EP2294067A1 Preparation of n-6 demethylated, 9-10-dihydrolysergic acid alkyl esters |
| 03/16/2011 | EP2294063A1 Pyrrolidine ether derivatives as nk3 receptor antagonists |
| 03/16/2011 | EP2294057A1 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293790A2 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 03/16/2011 | EP2293786A2 Tablettable chewing gums comprising nicotine and a buffering agent |
| 03/16/2011 | EP2293775A2 Hydrogel capable of containing and conveying cells |
| 03/16/2011 | EP2205575B1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 03/16/2011 | EP2132194B1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 03/16/2011 | EP2125786B1 Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline |
| 03/16/2011 | EP2094674B1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 03/16/2011 | EP2091939B1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 03/16/2011 | EP1968573B1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 03/16/2011 | EP1879856B1 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 03/16/2011 | EP1853285B1 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 03/16/2011 | EP1809598B1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 03/16/2011 | EP1513507B1 Transdermal analgesic systems with reduced abuse potential |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN1830447B Midazuolun maleate oral administration film agent and its preparation method |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985464A High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985438A Substituted phenyl piperazinyl aralkylone derivatives and application thereof to preparation of analgesics |
| 03/16/2011 | CN101985040A Novel medicinal composition |
| 03/16/2011 | CN101985036A Amyloid- beta (1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 03/16/2011 | CN101985033A Compound traditional Chinese medicine for treating stubborn diseases |
| 03/16/2011 | CN101985029A Cortex acanthopanacis wine |
| 03/16/2011 | CN101985019A Chinese medicinal preparation for treating dysthymia |
| 03/16/2011 | CN101985010A Chinese medicinal composition for treating insomnia caused by depression |
| 03/16/2011 | CN101985003A Medicinal liquor with effects of tonifying kidney and holding qi |
| 03/16/2011 | CN101985001A Chinese herbal medicine for treating insomnia |
| 03/16/2011 | CN101984992A Epilepsy-eliminating agent |
| 03/16/2011 | CN101984980A Extraction method, extract and pharmaceutical use of hypericum perforatum extract |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101984960A Rizatriptan benzoate capsule and preparation method thereof |
| 03/16/2011 | CN101575335B Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 03/16/2011 | CN101550111B Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole |
| 03/16/2011 | CN101474361B Chinese medicine for treating cerebropathy |
| 03/16/2011 | CN101417021B External traditional Chinese medicine for giving up drug habits and preparation method |
| 03/16/2011 | CN101381403B Alpha type conotoxin peptide derivates and use thereof |
| 03/16/2011 | CN101343253B 2-amido-4, 5-diaryl miazines compound, preparation and pharmaceutical use thereof |
| 03/16/2011 | CN101342217B Quick-effective pain relieving traditional Chinese medicine liniment for treating advanced cancer and preparation method thereof |
| 03/16/2011 | CN101337956B Scutellarein carbamate derivates, preparation method and application thereof |
| 03/16/2011 | CN101260075B Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament |
| 03/16/2011 | CN101244026B Huperzine and its derivant or its salt implantation agent, its preparation method and application |
| 03/16/2011 | CN101194934B Method for abstracting active compound rich in echinacoside and feltwort glycoside |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906626 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 03/15/2011 | US7906537 Substituted p-diaminobenzene derivatives |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2646163C 3,7-diamino-10h-phenothiazine salts and their use |
| 03/15/2011 | CA2613030C Agent for the treatment of herpes virus-derived pain |
| 03/15/2011 | CA2597154C Use of iron(iii) complex compounds |
| 03/15/2011 | CA2591053C Pyrimidinone compounds and preparation and use thereof |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2470583C Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| 03/15/2011 | CA2468311C Benzothiazole derivatives |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/15/2011 | CA2406064C Minimizing adverse experience associated with oxybutynin therapy |
| 03/15/2011 | CA2397681C Partially saturated calcium channel blockers |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2343009C Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
| 03/15/2011 | CA2315117C Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011029001A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028935A2 Methods of treating mitochondrial disorders using metalloporhyrins |
| 03/10/2011 | WO2011028875A1 Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028799A2 Ganglioside transmucosal formulations |
| 03/10/2011 | WO2011028794A2 Treatment of huntington's disease with cycloserine and an nmda receptor antagonist |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011028621A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists |
| 03/10/2011 | WO2011028580A1 Novel forms of a multicyclic compound |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011027805A1 Therapeutic agent for mood disorders |
| 03/10/2011 | WO2011027786A1 Transdermally absorbable preparation |
| 03/10/2011 | WO2011027289A1 Chromone derivatives, a process for their preparation and their therapeutic applications |
| 03/10/2011 | WO2011027106A1 Therapeutic aryl-am i do-aryl compounds and their use |
| 03/10/2011 | WO2011027009A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same |
| 03/10/2011 | WO2011026891A1 Substituted pyridine derivatives and their medical use |
| 03/10/2011 | WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | WO2011026240A1 Oxopiperazine derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | WO2011026216A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease |
| 03/10/2011 | WO2011008666A3 3-phenoxymethylpyrrolidine compounds |
| 03/10/2011 | WO2010129145A3 Methods and compositions for treating dry eye |